The Potential of IgG to Induce Murine and Human Thymic Maturation of IL-10+B Cells (B10) Revealed in a Pilot Study

Carregando...
Imagem de Miniatura
Citações na Scopus
9
Tipo de produção
article
Data de publicação
2020
Título da Revista
ISSN da Revista
Título do Volume
Editora
MDPI
Citação
CELLS, v.9, n.10, article ID 2239, 18p, 2020
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Regulatory B (B10) cells can control several inflammatory diseases, including allergies; however, the origin of peripheral B10 cells is not fully understood, and the involvement of primary lymphoid organs (PLOs) as a primary site of maturation is not known. Here, using a murine model of allergy inhibition mediated by maternal immunization with ovalbumin (OVA), we aimed to evaluate whether B10 cells can mature in the thymus and whether IgG can mediate this process. Female mice were immunized with OVA, and offspring thymus, bone marrow, spleen, lung, and serum samples were evaluated at different times and after passive transfer of purified IgG or thymocytes. A translational approach was implemented using human nonatopic thymus samples, nonatopic peripheral blood mononuclear cells (PBMCs), and IgG from atopic or nonatopic individuals. Based on the expression of CD1d on B cells during maturation stages, we suggest that B10 cells can also mature in the murine thymus. Murine thymic B10 cells can be induced in vitro and in vivo by IgG and be detected in the spleen and lungs in response to an allergen challenge. Like IgG from atopic individuals, human IgG from nonatopic individuals can induce B10 cells in the infant thymus and adult PBMCs. Our observations suggest that B10 cells may mature in the thymus and that this mechanism may be mediated by IgG in both humans and mice. These observations may support the future development of IgG-based immunoregulatory therapeutic strategies.
Palavras-chave
IgG, thymus, B cells, B10 cells, mouse, human
Referências
  1. Akashi K, 2000, J IMMUNOL, V164, P5221, DOI 10.4049/jimmunol.164.10.5221
  2. Amu S, 2010, J ALLERGY CLIN IMMUN, V125, P1114, DOI 10.1016/j.jaci.2010.01.018
  3. Audo R, 2014, ARTHRITIS RHEUMATOL, V66, pS168, DOI 10.1002/art.38666
  4. Carter NA, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3736
  5. Carter NA, 2011, J IMMUNOL, V186, P5569, DOI 10.4049/jimmunol.1100284
  6. Sgnotto FD, 2017, HUM VACC IMMUNOTHER, V13, P1563, DOI 10.1080/21645515.2017.1299299
  7. Lira AAD, 2018, ALLERGOL IMMUNOPATH, V46, P454, DOI 10.1016/j.aller.2018.04.001
  8. Lira AAD, 2014, ALLERGY ASTHMA CL IM, V10, DOI 10.1186/1710-1492-10-47
  9. de Oliveira MG, 2018, CENT EUR J IMMUNOL, V43, P378, DOI 10.5114/ceji.2018.81345
  10. de Oliveira MG, 2018, SCAND J IMMUNOL, V88, DOI 10.1111/sji.12721
  11. de Oliveira MG, 2017, ALLERGY ASTHMA CL IM, V13, DOI 10.1186/s13223-017-0195-8
  12. de-Oliveira MG, 2019, CLIN EXP ALLERGY, V49, P1000, DOI 10.1111/cea.13393
  13. DiLillo DJ, 2010, ANN NY ACAD SCI, V1183, P38, DOI 10.1111/j.1749-6632.2009.05137.x
  14. Ding Q, 2011, J CLIN INVEST, V121, P3645, DOI 10.1172/JCI46274
  15. Ellertsen LK, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-8
  16. Freer G, 2013, METHODS, V61, P30, DOI 10.1016/j.ymeth.2013.03.035
  17. Futata EA, 2006, IMMUNOBIOLOGY, V211, P157, DOI 10.1016/j.imbio.2005.08.006
  18. Gao N, 2014, ARTHRITIS RHEUMATOL, V66, P2849, DOI 10.1002/art.38742
  19. Heinzerling Lucie, 2013, Clin Transl Allergy, V3, P3, DOI 10.1186/2045-7022-3-3
  20. Hubeau C, 2006, AM J PATHOL, V168, P1931, DOI 10.2353/ajpath.2006.051231
  21. Jin GH, 2013, J ALLERGY CLIN IMMUN, V131, P1674, DOI 10.1016/j.jaci.2013.01.044
  22. Kabuto M, 2016, J DERMATOL, V43, P815, DOI 10.1111/1346-8138.13295
  23. Li JQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132173
  24. Matson AP, 2007, J IMMUNOL, V179, P1282, DOI 10.4049/jimmunol.179.2.1282
  25. Mauri C, 2012, ANNU REV IMMUNOL, V30, P221, DOI 10.1146/annurev-immunol-020711-074934
  26. Mavropoulos A, 2017, CLIN IMMUNOL, V184, P26, DOI 10.1016/j.clim.2017.04.013
  27. Mavropoulos A, 2017, CLIN IMMUNOL, V184, P33, DOI 10.1016/j.clim.2017.04.010
  28. Morlacchi S, 2011, BLOOD, V118, P984, DOI 10.1182/blood-2011-02-336115
  29. Muniz BP, 2014, IMMUNOBIOLOGY, V219, P377, DOI 10.1016/j.imbio.2014.01.002
  30. Noh G, 2011, ALLERGY ASTHMA IMMUN, V3, P168, DOI 10.4168/aair.2011.3.3.168
  31. Oliveira CR, 2005, J CLIN IMMUNOL, V25, P153, DOI 10.1007/s10875-005-2821-3
  32. PADBERG WM, 1987, J IMMUNOL, V139, P1751
  33. Santos LS, 2020, INT J DERMATOL, V59, P359, DOI 10.1111/ijd.14688
  34. Santos LS, 2019, ARCH IMMUNOL THER EX, V67, P263, DOI 10.1007/s00005-019-00545-6
  35. Sato MN, 2001, J INTERF CYTOK RES, V21, P827, DOI 10.1089/107999001753238079
  36. Sgnotto FDR, 2018, INT J DERMATOL, V57, P434, DOI 10.1111/ijd.13907
  37. Sgnotto FD, 2019, JAIDS-J ACQ IMM DEF, V82, pE56, DOI 10.1097/QAI.0000000000002182
  38. van Rijt LS, 2004, J IMMUNOL METHODS, V288, P111, DOI 10.1016/j.jim.2004.03.004
  39. Verhasselt V, 2008, NAT MED, V14, P170, DOI 10.1038/nm1718
  40. Victor JR, 2020, IMMUNOL CELL BIOL, V98, P540, DOI 10.1111/imcb.12335
  41. Victor JR, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-11
  42. Victor JR, 2017, HUM VACC IMMUNOTHER, V13, P507, DOI 10.1080/21645515.2016.1244592
  43. Victor JR, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/780386
  44. Walters SN, 2014, J IMMUNOL, V193, P170, DOI 10.4049/jimmunol.1302519
  45. Xing C, 2015, J LEUKOCYTE BIOL, V97, P547, DOI 10.1189/jlb.3A0414-213RR
  46. Yanaba K, 2008, IMMUNITY, V28, P639, DOI 10.1016/j.immuni.2008.03.017
  47. Yanaba K, 2011, AM J PATHOL, V178, P735, DOI 10.1016/j.ajpath.2010.10.022
  48. Yoshizaki A, 2012, NATURE, V491, P264, DOI 10.1038/nature11501
  49. Zhu HQ, 2015, BRIT J DERMATOL, V172, P101, DOI 10.1111/bjd.13192